1 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug ... Phosphodiesterase-4 (PDE4) Inhibitor ... Dosing: 250 mcg tablet ... recommendations for the treatment ... #Indications #Pharmacology